πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 379 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7485709

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485306

Lutzomyia longipalpis polypeptides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432236

Vasostatin as marrow protectant

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432067

Methods of detection of MATER protein autoantibodies

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides f

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427590

Neurothrophic components of the ADNF I complex

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7425611

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7419957

Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic met

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371225

Method for convection enhanced delivery of therapeutic agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355012

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348319

Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7320991

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7317086

Basal cell carcinoma tumor suppressor protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314632

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7312228

Cytotoxic indeno and isoindoloisoquinolones

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300940

Integrin Ξ±-v Ξ²-3 antagonists for use in imaging and therapy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7282205

Anti-hepatitis A virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7267941

Cyanovirin variant-polymer conjugates

Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264947

Activity dependent neurotrophic factor III (ADNF III)

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7261896

Methods for preventing strokes by inducing tolerance to e-selectin

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7258859

Method for the treatment of multiple sclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted